We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Mr
Binoy
Kumaran
+44 (0)7517430077
b.r.kumaran@herts.ac.uk
Mr
Tim
Watson
+44 (0)1707 284000
t.watson@herts.ac.uk
Osteoarthritis (OA) of the knee joint
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Osteoarthritis (OA), the most common type of arthritis, is a condition that causes joints to become painful and stiff. OA typically affects the knees, hips and small joints of the hands. OA is an incurable, long term condition but there are a number of ways to improve symptoms, such as maintaining a healthy weight and regularly exercising. Unfortunately, OA of the knee can often result in disability and make it hard for people to carry out their normal daily activities. It can also make it difficult for people to exercise. Physiotherapists can help people put together an exercise plan to manage their symptoms. They can also provide various treatments to reduce pain and swelling in the joints, such as radiofrequency (RF) therapy. RF therapy generates heat in the tissues of the affected area, which increases blood flow and relieves pain and inflammation. The standard RF therapy given to patients is shortwave therapy, which delivers a 27.12 Megahertz frequency to the affected joint. There are various types of devices available, including ones that operate at very low frequencies (below 1 Megahertz), although it is not clear how well they actually work. Capacitive Resistive Monopolar Radiofrequency (CRMRF) (448 Kilohertz) is one such low frequency device. The aim of this study is to see how well CRMRF therapy works to relieve pain and improve quality of life in patients suffering from chronic OA of the knee compared to standard therapy. CRMRF will be delivered using the Indiba Activ 902 device.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
2019 Results article in https://pubmed.ncbi.nlm.nih.gov/30269963/ results (added 02/09/2020)
You can take part if:
You may not be able to take part if:
1. Significant underlying medical conditions2. OA of other joints such as hip or ankle3. Currently receiving/received (in the last six months) treatment (including invasive procedures) other than standard care4. Inability to consent
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Mr
Tim
Watson
+44 (0)1707 284000
t.watson@herts.ac.uk
Mr
Binoy
Kumaran
+44 (0)7517430077
b.r.kumaran@herts.ac.uk
The study is sponsored by University of Hertfordshire and funded by INDIBA SA (Spain).
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
